On Nov. 4, Oracle closed two capital-market offerings with a combined gross value of $20 billion, splitting the financing between common stock and senior debt.
The share sale covered 86,206,897 common shares at $116 apiece. The debt issue totaled $10 billion in principal. The $20 billion figure represents the offerings’ gross size, not confirmed net proceeds.
Oracle set the terms on Nov. 2, as described in EconoTimes’ earlier report on the pricing. At that time, the company estimated net proceeds of about $9.9 billion from the stock sale and about $10 billion from the notes after discounts and expenses.
The senior notes comprise five series: $2 billion due in 2029 at 7%; $1.75 billion due in 2031 at 7.45%; $2.25 billion due in 2033 at 7.85%; $2.5 billion due in 2037 at 8%; and $1.5 billion due in 2046 at 8.65%, according to Oracle’s pricing announcement.
Oracle said the proceeds would be available for general corporate purposes. Possible uses include capital expenditures, debt repayment, investments or acquisitions, dividends and share repurchases.
The offerings are part of Oracle’s additional capital-market funding plan for its fiscal 2027-30 investment cycle. In its Oct. 28 plan, the company set a $20 billion limit on that financing, excluding refinancing, with equity and gross debt each expected to account for $10 billion. The plan was separate from a $20 billion at-the-market equity raise completed in the first quarter of fiscal 2027.
